(Q45175612)

English

Vioxx, the implosion of Merck, and aftershocks at the FDA.

scientific article published in December 2004

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

title

Vioxx, the implosion of Merck, and aftershocks at the FDA. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10 December 2017

1

Richard Horton

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

number of pages

2

1 reference

based on heuristic

inferred from page(s)

published in

The Lancet

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

volume

364

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

issue

9450

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

page(s)

1995-1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

cites work

Vioxx: an unequal partnership between safety and efficacy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917523-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Failing the public health--rofecoxib, Merck, and the FDA.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917523-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(04)17523-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

PubMed publication ID

15582041

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15582041

retrieved

10 December 2017

(Q45175612)

Vioxx, the implosion of Merck, and aftershocks at the FDA.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)